SILENCE THERAPEUTICS PLC-ADR (SLN) Stock Balance Sheet
NASDAQ:SLN - Nasdaq - US82686Q1013 - ADR - Currency: USD
| MRQ (2024-6-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 12.45M | N/A | N/A | N/A | |||
| Cash Equivalents | 109.48M | N/A | 13.52M | 21.49M | 42.74M | |||
| Marketable Securities | 40.11M | 25.00M | 20.00M | 5.04M | N/A | |||
| Receivables | 14.54M | 33.52M | 3.52M | 2.45M | 1.97M | |||
| Other Current Assets | 12.24M | 5.43M | 431.00K | 515.00K | 836.00K | |||
| Total Current Assets | 176.38M | 76.40M | 37.47M | 29.50M | 45.55M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.69M | 1.13M | 611.00K | 921.00K | 1.17M | |||
| Investments And Advances | 284.00K | 303.00K | 275.00K | 275.00K | 0.00 | |||
| Goodwill | 7.66M | N/A | 7.69M | 8.13M | 8.03M | |||
| Intangibles | 267.00K | 17.00K | 34.00K | 64.00K | 28.00K | |||
| Other Non-Current Assets | 2.36M | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 12.26M | 9.57M | 8.61M | 9.39M | 9.46M | |||
| TOTAL ASSETS | 188.64M | 85.97M | 46.08M | 38.88M | 55.01M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 184.00K | 341.00K | 287.00K | N/A | N/A | |||
| Accrued Expenses | N/A | 5.91M | 5.10M | 2.66M | 2.19M | |||
| Accounts Payable | 14.99M | 2.29M | 1.79M | 1.15M | 462.00K | |||
| Other Current Liabilities | 2.77M | 17.04M | 2.48M | 27.00K | N/A | |||
| Total Current Liabilities | 17.94M | 25.57M | 9.65M | 3.83M | 2.66M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 58.19M | 51.34M | 15.52M | N/A | N/A | |||
| Total Non-Current Liabilities | 58.19M | 51.34M | 15.52M | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 76.13M | 76.91M | 25.17M | 3.83M | 2.66M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -253.20M | -151.06M | -122.91M | -103.90M | -86.17M | |||
| Additional Paid In Capital | 356.88M | 153.73M | 138.15M | 133.24M | 132.96M | |||
| Common Shares | 7.02M | 4.17M | 3.92M | 3.55M | 3.50M | |||
| Other Shareholders' Equity | 1.81M | 2.22M | 1.75M | 2.16M | 2.06M | |||
| Shares Outstanding | 47.28M | 83.31M | 78.37M | 71.07M | 69.99M | |||
| Tangible Book Value per Share | 0.74 | 0.01 | 0.17 | 0.38 | 0.63 | |||
| Total Shareholders' Equity | 112.51M | 9.06M | 20.91M | 35.05M | 52.35M | |||
| TOTAL LIABILITIES AND EQUITY | 188.64M | 85.97M | 46.08M | 38.88M | 55.01M | |||
| Statistics | ||||||||
| Current Ratio | 9.83 | 2.99 | 3.88 | 7.70 | 17.14 | |||
| Return On Assets (ROA) | -21.26% | -37.86% | -42.50% | -47.35% | -2.94% | |||
| Return On Equity (ROE) | -35.64% | -359.28% | -93.65% | -52.52% | -3.09% | |||
All data in GBP , ROIC based on taxRate of 0.25